Combo Therapy May Be Best Option For Kidney Cancer Patients, Sponsors

Developing combination regimens may provide optimal therapy for renal cell carcinoma patients and, simultaneously, allow manufacturers to avoid partitioning off the relatively limited kidney cancer market, Genentech VP-Clinical Oncology Gwen Fyfe suggested